Launch Date
10/03/2024
Credit Amount
1.5
Credit Expires
10/03/2025
The 2022 Clinical Practice Guideline for Prescribing Opioids for Pain, developed by the Centers for Disease Control and Prevention (CDC), was introduced as an update to the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. This update aimed to bridge practice gaps and correct misapplication of the 2016 guideline that resulted in patient harm. Unfortunately, interpretation and misapplication of the recommendations have posed challenges to patient-clinician relationships and has widened gaps of inequitable access to pain management solutions, reminding us that there are no short cuts to safer opioid prescribing.
In this CME Outfitters webcast entitled, Revolutionizing Pain Care: Applying the Latest Opioid REMS Education to Your Practice, a panel of expert faculty will discuss the 2022 CDC Guideline for Prescribing Opioids for Chronic Pain, changes made since the last Guideline published in 2016, and ways to utilize the new Guideline in the management of pain. Emphasis will be on the need to individualize treatment to the needs of the patient, use of multi-modal pain management strategies, understanding the different pain pathways and biopsychosocial factors individual patients face trying to manage pain.
At the conclusion of this activity, learners will be able to better:
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies.
Please click here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
Physicians, dentists, physician associates (PAs), nurse practitioners (NPs), nurses, psychologists, and pharmacists
In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME Outfitters, LLC, designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This application-based activity is approved for 1.50 contact hours ( 0.15 CEUs) of continuing pharmacy credit ( JA0007185-0000-24-084-H01-P ).
This activity is designated for 1.50 contact hours.
California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.
This activity was planned by and for the healthcare team, and learners will receive 1.50 Interprofessional Continuing Education Credit for learning and change.
CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.50 AAPA Category 1 CME credits. Approval is valid until 10/03/25. PAs should only claim credit commensurate with the extent of their participation.
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibly for the content of the programs.
CME Outfitters, LLC is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
CME Outfitters, LLC designates this activity for 1.50 continuing education credits.
Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
The AAFP has reviewed Revolutionizing Pain Care: Applying the Latest Updates in Opioid REMS Education to Your Practice and deemed it acceptable for up to 1.50 enduring material AAFP credit(s). Term of Approval is from 10/07/2024 to 10/07/25. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Dr. Goree reports the following financial relationships:
Consultant: Abbott; Saluda Medical; and Stratus Medical, LLC
Research Support: Mainstay Medical and SPR Therapeutics
Dr. Schatman reports the following financial relationships:
Financial or material support: Senior Medical Advisor – Apurano Pharmaceuticals
Dr. Singh reports no financial relationships to disclose.
The following individuals have no financial relationships to disclose:
Thomas W. Heinrich, MD (Peer Reviewer (AAFP)
Michael Franks, APRN, AGACNP-BC, FNP-BC (Peer Reviewer)
Evan Luberger (Planning Committee)
Kasey Brandt, PharmD (Planning Committee)
Michael E. Schatman, PhD (Planning Committee APA)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)
Call us at 877.CME.PROS (877.263.7767).
WCV-087-100324-62